- Home
- ARQT vs XMTR Comparison
ARQT vs XMTR Comparison
Compare ARQT & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- XMTR
- Stock Information
- Founded
- ARQT 2016
- XMTR 2013
- Country
- ARQT United States
- XMTR United States
- Employees
- ARQT N/A
- XMTR N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- XMTR Industrial Machinery/Components
- Sector
- ARQT Health Care
- XMTR Technology
- Exchange
- ARQT Nasdaq
- XMTR Nasdaq
- Market Cap
- ARQT 1.1B
- XMTR 1.0B
- IPO Year
- ARQT 2020
- XMTR 2021
- Fundamental
- Price
- ARQT $13.08
- XMTR $34.06
- Analyst Decision
- ARQT Strong Buy
- XMTR Buy
- Analyst Count
- ARQT 5
- XMTR 10
- Target Price
- ARQT $17.00
- XMTR $34.33
- AVG Volume (30 Days)
- ARQT 2.0M
- XMTR 730.5K
- Earning Date
- ARQT 02-25-2025
- XMTR 02-27-2025
- Dividend Yield
- ARQT N/A
- XMTR N/A
- EPS Growth
- ARQT N/A
- XMTR N/A
- EPS
- ARQT N/A
- XMTR N/A
- Revenue
- ARQT $138,708,000.00
- XMTR $525,128,000.00
- Revenue This Year
- ARQT $209.03
- XMTR $19.61
- Revenue Next Year
- ARQT $49.00
- XMTR $19.11
- P/E Ratio
- ARQT N/A
- XMTR N/A
- Revenue Growth
- ARQT 182.84
- XMTR 21.19
- 52 Week Low
- ARQT $3.59
- XMTR $11.08
- 52 Week High
- ARQT $16.20
- XMTR $45.33
- Technical
- Relative Strength Index (RSI)
- ARQT 46.24
- XMTR 42.79
- Support Level
- ARQT $12.61
- XMTR $33.13
- Resistance Level
- ARQT $14.36
- XMTR $35.07
- Average True Range (ATR)
- ARQT 0.98
- XMTR 2.13
- MACD
- ARQT -0.32
- XMTR -1.16
- Stochastic Oscillator
- ARQT 13.09
- XMTR 14.50
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of the revenue is earned from the U.S. segment.